New insights to the MLL recombinome of acute leukemias (original) (raw)

References

1. Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909–1915.
   Article PubMed Google Scholar
2. Pui CH, Chessells JM, Camitta B, Baruchel A, Biondi A, Boyett JM et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003; 17: 700–706.
   Article CAS PubMed Google Scholar
3. Johansson B, Moorman AV, Secker-Walker LM . Derivative chromosomes of 11q23-translocations in hematologic malignancies. European 11q23 Workshop participants. Leukemia 1998; 12: 828–833.
   Article CAS PubMed Google Scholar
4. Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME et al. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11)—a report of the Children's Cancer Group. Leukemia 1999; 13: 679–686.
   Article CAS PubMed Google Scholar
5. van der Burg M, Beverloo HB, Langerak AW, Wijsman J, van Drunen E, Slater R et al. Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set. Leukemia 1999; 13: 2107–2113.
   Article CAS PubMed Google Scholar
6. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004; 18: 895–908.
   Article CAS PubMed Google Scholar
7. Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL et al. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study. Br J Haematol 2005; 129: 520–530.
   Article PubMed Google Scholar
8. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT–PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928.
   Article CAS PubMed Google Scholar
9. Reichel M, Gillert E, Angermüller S, Hensel JP, Heidel F, Lode M et al. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 2001; 20: 2900–2907.
   Article CAS PubMed Google Scholar
10. Langer T, Metzler M, Reinhardt D, Viehmann S, Borkhardt A, Reichel M et al. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides. Genes Chrom Cancer 2003; 36: 393–401.
    Article CAS PubMed Google Scholar
11. Meyer C, Schneider B, Reichel M, Angermueller S, Strehl S, Schnittger S et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci USA 2005; 102: 449–454.
    Article CAS PubMed Google Scholar
12. Meyer C, Schneider B, Jakob S, Strehl S, Schnittger S, Schoch C et al. The MLL recombinome of acute leukemias. Leukemia 2006; 20: 777–784.
    Article CAS PubMed Google Scholar
13. Daser A, Rabbitts TH . The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol 2005; 15: 175–188.
    Article CAS PubMed Google Scholar
14. Krivtsov AV, Armstrong SA . MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 2007; 7: 823–833.
    Article CAS PubMed Google Scholar
15. Lykke-Andersen J . Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol Cell Biol 2002; 22: 8114–8121.
    Article CAS PubMed PubMed Central Google Scholar
16. Moncman CL, Wang K . Targeted disruption of nebulette protein expression alters cardiac myofibril assembly and function. Exp Cell Res 2002; 273: 204–218.
    Article CAS PubMed Google Scholar
17. Carén H, Holmstrand A, Sjöberg RM, Martinsson T . The two human homologues of yeast UFD2 ubiquitination factor, UBE4A and UBE4B, are located in common neuroblastoma deletion regions and are subject to mutations in tumours. Eur J Cancer 2006; 42: 381–387.
    Article PubMed Google Scholar
18. Bartolomé RA, Molina-Ortiz I, Samaniego R, Sánchez-Mateos P, Bustelo XR, Teixidó J . Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res 2006; 66: 248–258.
    Article PubMed PubMed Central Google Scholar
19. Kikuchi S, Honda K, Tsuda H, Hiraoka N, Imoto I, Kosuge T et al. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res 2008; 14: 5348–5356.
    Article CAS PubMed Google Scholar
20. Ding Z, Liang J, Lu Y, Yu Q, Songyang Z, Lin SY et al. A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners. Proc Natl Acad Sci USA 2006; 103: 15014–15019.
    Article CAS PubMed PubMed Central Google Scholar
21. Talior-Volodarsky I, Randhawa VK, Zaid H, Klip A . Alpha-actinin-4 is selectively required for insulin-induced GLUT4 translocation. J Biol Chem 2008; 283: 25115–25123.
    Article CAS PubMed Google Scholar
22. Browne KA, Johnstone RW, Jans DA, Trapani JA . Filamin (280-kDa actin-binding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis. J Biol Chem 2000; 275: 39262–39266.
    Article CAS PubMed Google Scholar
23. Loy CJ, Sim KS, Yong EL . Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 2003; 100: 4562–4567.
    Article CAS PubMed PubMed Central Google Scholar
24. Stahlhut M, van Deurs B . Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell 2000; 11: 325–337.
    Article CAS PubMed PubMed Central Google Scholar
25. Fiucci G, Ravid D, Reich R, Liscovitch M . Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 2002; 21: 2365–2375.
    Article CAS PubMed Google Scholar
26. Reichel M, Gillert E, Nilson I, Siegler G, Greil J, Fey GH et al. Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation. Oncogene 1998; 17: 3035–3044.
    Article CAS PubMed Google Scholar
27. Richardson C, Jasin M . Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 2000; 405: 697–700.
    Article CAS PubMed Google Scholar
28. Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD, Croce CM . ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994; 91: 6236–6239.
    Article CAS PubMed PubMed Central Google Scholar
29. Caligiuri MA, Strout MP, Schichman SA, Mrozek K, Arthur DC, Herzig GP et al. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 1996; 56: 1418–1425.
    CAS PubMed Google Scholar
30. Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 2000; 14: 796–804.
    Article CAS PubMed Google Scholar
31. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 2003; 4: 197–207.
    Article CAS PubMed Google Scholar
32. Bäsecke J, Whelan JT, Griesinger F, Bertrand FE . The MLL partial tandem duplication in acute myeloid leukaemia. Br J Haematol 2006; 135: 438–449.
    Article PubMed Google Scholar
33. Shih LY, Liang DC, Fu JF, Wu JH, Wang PN, Lin TL et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia 2006; 20: 218–223.
    Article CAS PubMed Google Scholar
34. Meyer C, Burmeister T, Strehl S, Schneider B, Hubert D, Zach O et al. Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. Leukemia 2007; 21: 588–590.
    Article CAS PubMed Google Scholar
35. Aspland SE, Bendall HH, Murre C . The role of E2A-PBX1 in leukemogenesis. Oncogene 2001; 20: 5708–5717.
    Article CAS PubMed Google Scholar
36. Scharf S, Zech J, Bursen A, Schraets D, Oliver PL, Kliem S et al. Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL gene. Oncogene 2007; 26: 1361–1371.
    Article CAS PubMed Google Scholar
37. Burmeister T, Marschalek R, Schneider B, Meyer C, Gökbuget N, Schwartz S et al. Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia 2006; 20: 451–457.
    Article CAS PubMed Google Scholar
38. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM et al. hDOT1L links histone methylation to leukemogenesis. Cell 2005; 121: 167–178.
    Article CAS PubMed Google Scholar
39. Zeisig DT, Bittner CB, Zeisig BB, García-Cuéllar MP, Hess JL, Slany RK . The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene 2005; 24: 5525–5532.
    Article CAS PubMed Google Scholar
40. Bitoun E, Oliver PL, Davies KE . The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum Mol Genet 2007; 16: 92–106.
    Article CAS PubMed Google Scholar
41. Zhang Y, Reinberg D . Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 2001; 15: 2343–2360.
    Article CAS PubMed Google Scholar
42. Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, Sinha AU et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 2008; 14: 355–368.
    Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

This work was made possible by and conducted within the framework of the International BFM Study Group. This study was supported by grant 107819 from the Deutsche Krebshilfe to RM, TD and TK; supported by grant R06/22 from the German José Carreras Leukemia foundation to TB and supported by grant 2 P054 095 30 from the Polish Ministry of Science and Higher Education to TS.

Author information

Authors and Affiliations

1. Diagnostic Center of Acute Leukemia, Institute of Pharmaceutical Biology, ZAFES, University of Frankfurt, Frankfurt/Main, Germany
   C Meyer, E Kowarz, J Hofmann, T Dingermann & R Marschalek
2. Department of Hematology, Biology and Pathology Center, CHU of Lille, Lille, France
   A Renneville
3. INSERM, U-837, Team 3, Lille, France
   A Renneville
4. Department of Paediatric Haematology/Oncology, CLIP, Second Faculty of Medicine, Charles University Prague, Prague, Czech Republic
   J Zuna & J Trka
5. Biological Hematology, AP-HP Necker, UniversitéParis Descartes, Paris, France
   R Ben Abdelali & E Macintyre
6. Faculté de Médecine et des Sciences de la Santé, Laboratoire d'Histologie, Embryologie et Cytogénétique, Université de Bretagne Occidentale, Brest, France
   E De Braekeleer & M De Braekeleer
7. INSERM-U613, Brest, France
   E De Braekeleer & M De Braekeleer
8. CHU Purpan, Laboratoire d’Hématologie, Toulouse, France
   E Delabesse
9. Pediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Cancer Rio de Janeiro, Rio de Janeiro, Brazil
   M P de Oliveira
10. Département de Génétique, Hopital Robert Debré, Paris, France
    H Cavé & E Clappier
11. Department of Immunology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands
    J J M van Dongen
12. Department of Pediatric Oncology/Hematology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands
    B V Balgobind & M M van den Heuvel-Eibrink
13. Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands
    H B Beverloo
14. Children's Cancer Research Institute, Vienna, Austria
    R Panzer-Grümayer & S Strehl
15. Department of Pediatric Hematology and Oncology, Children's University Hospital, Giessen, Germany
    A Teigler-Schlegel & J Harbott
16. Cancercytogenetics Laboratory, Aarhus University Hospital, Aarhus, Denmark
    E Kjeldsen
17. MLL Munich Leukemia Laboratory, Munich, Germany
    S Schnittger
18. Department of Pediatric Hematology and Oncology, University of Frankfurt, Frankfurt/Main, Germany
    U Koehl & T Klingebiel
19. Department of Pediatrics, University of Jena, Jena, Germany
    B Gruhn
20. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK
    O Heidenreich
21. Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
    L C Chan & S F Yip
22. Canada's Michael Smith Genome Sciences Center, Vancouver, British Columbia, Canada
    M Krzywinski
23. Department of Pediatric Oncology and Hematology, Charité Medical University Berlin, CVK, Berlin, Germany
    C Eckert
24. Department of Paediatrics, University of Schleswig-Holstein, Kiel, Germany
    A Möricke & M Schrappe
25. Servcio de Hemato-Oncología, Hospital Nacional de Pediatría Prof Dr JP Garrahan, Buenos Aires, Argentina
    C N Alonso
26. Department of Oncology, University Children's Hospital, Zurich, Switzerland
    B W Schäfer
27. Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hanover Medical School, Hanover, Germany
    J Krauter
28. Division of Pediatrics, Cell Therapy Section, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    D A Lee
29. Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    U zur Stadt
30. Department of Paediatrics and Oncohematology, University of Padua, Padua, Italy
    G Te Kronnie
31. Sydney Children's Hospital, Children's Cancer Institute, Sydney, New South Wales, Australia
    R Sutton
32. Department of Pediatric Hemato-Oncology, The Chaim Sheba Medical Center, Tel Aviv, Israel
    S Izraeli & L Trakhtenbrot
33. The Cancer Research Center, Tel Aviv, Israel
    S Izraeli & L Trakhtenbrot
34. Sackler Medical School Tel Aviv University, Tel Aviv, Israel
    S Izraeli & L Trakhtenbrot
35. Center of Pediatric Hematology Oncology, University of Catania, Catania, Italy
    L Lo Nigro
36. Regional Children Hospital 1, Pediatric Oncology and Hematology Center, Research Institute of Medical Cell Technologies, Ekaterinburg, Russia
    G Tsaur & L Fechina
37. Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland
    T Szczepanski
38. Department of Clinical Genetics, National Cancer Hospital, Bratislava, Slovakia
    D Ilencikova
39. Medical Faculty III, CBF, Charité Medical University Berlin, Berlin, Germany
    M Molkentin & T Burmeister

Authors

1. C Meyer
   You can also search for this author inPubMed Google Scholar
2. E Kowarz
   You can also search for this author inPubMed Google Scholar
3. J Hofmann
   You can also search for this author inPubMed Google Scholar
4. A Renneville
   You can also search for this author inPubMed Google Scholar
5. J Zuna
   You can also search for this author inPubMed Google Scholar
6. J Trka
   You can also search for this author inPubMed Google Scholar
7. R Ben Abdelali
   You can also search for this author inPubMed Google Scholar
8. E Macintyre
   You can also search for this author inPubMed Google Scholar
9. E De Braekeleer
   You can also search for this author inPubMed Google Scholar
10. M De Braekeleer
    You can also search for this author inPubMed Google Scholar
11. E Delabesse
    You can also search for this author inPubMed Google Scholar
12. M P de Oliveira
    You can also search for this author inPubMed Google Scholar
13. H Cavé
    You can also search for this author inPubMed Google Scholar
14. E Clappier
    You can also search for this author inPubMed Google Scholar
15. J J M van Dongen
    You can also search for this author inPubMed Google Scholar
16. B V Balgobind
    You can also search for this author inPubMed Google Scholar
17. M M van den Heuvel-Eibrink
    You can also search for this author inPubMed Google Scholar
18. H B Beverloo
    You can also search for this author inPubMed Google Scholar
19. R Panzer-Grümayer
    You can also search for this author inPubMed Google Scholar
20. A Teigler-Schlegel
    You can also search for this author inPubMed Google Scholar
21. J Harbott
    You can also search for this author inPubMed Google Scholar
22. E Kjeldsen
    You can also search for this author inPubMed Google Scholar
23. S Schnittger
    You can also search for this author inPubMed Google Scholar
24. U Koehl
    You can also search for this author inPubMed Google Scholar
25. B Gruhn
    You can also search for this author inPubMed Google Scholar
26. O Heidenreich
    You can also search for this author inPubMed Google Scholar
27. L C Chan
    You can also search for this author inPubMed Google Scholar
28. S F Yip
    You can also search for this author inPubMed Google Scholar
29. M Krzywinski
    You can also search for this author inPubMed Google Scholar
30. C Eckert
    You can also search for this author inPubMed Google Scholar
31. A Möricke
    You can also search for this author inPubMed Google Scholar
32. M Schrappe
    You can also search for this author inPubMed Google Scholar
33. C N Alonso
    You can also search for this author inPubMed Google Scholar
34. B W Schäfer
    You can also search for this author inPubMed Google Scholar
35. J Krauter
    You can also search for this author inPubMed Google Scholar
36. D A Lee
    You can also search for this author inPubMed Google Scholar
37. U zur Stadt
    You can also search for this author inPubMed Google Scholar
38. G Te Kronnie
    You can also search for this author inPubMed Google Scholar
39. R Sutton
    You can also search for this author inPubMed Google Scholar
40. S Izraeli
    You can also search for this author inPubMed Google Scholar
41. L Trakhtenbrot
    You can also search for this author inPubMed Google Scholar
42. L Lo Nigro
    You can also search for this author inPubMed Google Scholar
43. G Tsaur
    You can also search for this author inPubMed Google Scholar
44. L Fechina
    You can also search for this author inPubMed Google Scholar
45. T Szczepanski
    You can also search for this author inPubMed Google Scholar
46. S Strehl
    You can also search for this author inPubMed Google Scholar
47. D Ilencikova
    You can also search for this author inPubMed Google Scholar
48. M Molkentin
    You can also search for this author inPubMed Google Scholar
49. T Burmeister
    You can also search for this author inPubMed Google Scholar
50. T Dingermann
    You can also search for this author inPubMed Google Scholar
51. T Klingebiel
    You can also search for this author inPubMed Google Scholar
52. R Marschalek
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toR Marschalek.

Additional information

Supplementary information

Rights and permissions

About this article

Cite this article

Meyer, C., Kowarz, E., Hofmann, J. et al. New insights to the MLL recombinome of acute leukemias.Leukemia 23, 1490–1499 (2009). https://doi.org/10.1038/leu.2009.33

Download citation

• Received: 09 December 2008
• Revised: 15 January 2009
• Accepted: 28 January 2009
• Published: 05 March 2009
• Issue Date: August 2009
• DOI: https://doi.org/10.1038/leu.2009.33

Keywords